Cadrenal Therapeutics Financial Ratios for Analysis 2022-2024 | CVKD

Fifteen years of historical annual and quarterly financial ratios and margins for Cadrenal Therapeutics (CVKD).

Annual Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
20232022
10.270.55
--0.11
--0.11
--
--
--
--
--
--
--
--
--
--
-108.64121
-108.64121
-98.10-862.83
-108.64134
8.86-10.16
-3.92-2.29
-3.93-2.29

Quarterly Data

Metric Name
Current Ratio
Long-term Debt / Capital
Debt/Equity Ratio
Gross Margin
Operating Margin
EBIT Margin
EBITDA Margin
Pre-Tax Profit Margin
Net Profit Margin
Asset Turnover
Inventory Turnover Ratio
Receiveable Turnover
Days Sales In Receivables
ROE - Return On Equity
Return On Tangible Equity
ROA - Return On Assets
ROI - Return On Investment
Book Value Per Share
Operating Cash Flow Per Share
Free Cash Flow Per Share
2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-31
3.728.2110.2716.469.4011.050.55---
-------0.11---
-------0.11---
----------
----------
----------
----------
----------
----------
----------
----------
----------
----------
-59.94-26.86-14.87-11.85-31.58-127.2690.42---
-59.94-26.86-14.87-11.85-31.58-127.2690.42---
-43.85-23.60-13.43-11.13-28.18-115.43-645.02---
-59.94-26.86-14.87-11.85-31.58-127.26100---
3.745.808.8610.074.065.20-10.16---
-3.15-1.72-3.92-2.76-2.82-1.97-2.29-1.71-0.96-0.09
-3.15-1.72-3.93-2.76-2.83-1.97-2.29-1.71-0.96-0.09